… (anti-TNF) antagonists have been the mainstay in the treatment of inflammatory bowel
diseases (… Summary: This review article aimed to provide an update on recent advances in TNF …

… (Crohn’s disease OR inflammatory bowel disease OR ulcerative … (tumor necrosis factor OR
tumor necrosis factor-alpha OR TNF) AND (Crohn’s disease OR inflammatory bowel disease …

… bowel disease and targeted oral anti-TNF α therapy … diseases, with immunotherapy
revolutionising the treatment of several inflammatory disorders including inflammatory bowel disease …

… Anti-tumor necrosis factor-α (TNF-α) is used for the treatment of severe cases of IBD, including
Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do not …

… Neutralizing tumour necrosis factor (TNF) antibodies have been widely used to treat
inflammatory bowel disease (IBD) in the clinical practice. In this review, the principal biomarker …

… Tumour necrosis factor (TNF)-α inhibitors have been widely used for the treatment of
moderate-to-severe inflammatory bowel disease (IBD). TNFα also plays an important role in the …

… IL-17, interferon γ, and tumor necrosis factor α that feed into a self-sustaining amplification …
, macrophages, fibroblasts, and endothelial cells to produce tumor necrosis factor α, IL-1, IL-6, …

… As described above, myelitis has an auto-immune mechanism and can be due to IBD
itself, comorbid MS or to anti-TNF α therapy. A slowly progressive spastic paraparesis due to …

… For patients commencing anti-TNF therapy who have specific cardiac risk factors such as
hypertension, valve disorders or ischaemic heart disease, our recommendation is that …

… managing inflammatory bowel disease (IBD) patients during the coronavirus 2019 disease
(… to the severity of the outbreak and of the disease). We agree with this recommendation that …